+44 (0) 1223 755950
+1 832 327 7413
Click on the image to see the image legend
Target | SARS-CoV E |
Origin | Virus |
Expression | Recombinant |
Tested Applications | ELISA, WB |
Host | E. coli |
Recommended dilutions | Optimal dilutions/concentrations should be determined by the end user. |
Conjugation | Unconjugated |
Form | Liquid |
Purity | > 95% (10% PAGE, Coomassie staining) |
Purification | GS-4B Sepharose-Affinity Purification |
Storage | Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles. |
UniProt Primary AC | P59637 (UniProt, ExPASy) |
UniProt Secondary AC | Q7TA13, Q7TFA8 |
UniProt Entry Name | VEMP_CVHSA |
Gene Symbol | E |
GeneID | 1489671 |
KEGG | vg:1489671 |
Molecular Weight | 34.7 kDa. May appear as multiple bands on SDS-PAGE (intact protein at 34.7 kDa, GST fusion protein at 26 kDa, and the E fragment at 12 kDa). |
Sequence Fragment | Contains the E protein immunodominant region. Not full-length E protein. The exact sequence is proprietary. |
Tag | GST tag |
Buffer | 50 mM Tris-HCl, pH 8.0, containing 60 mM NaCl and 50% Glycerol. Does not contain preservatives. |
Specificity | Immunoreactive with SARS positive sera. |
Concentration | 1 mg/ml |
Availability | Shipped within 10-20 working days. |
Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |
Directions for use | Centrifuge before opening to ensure complete recovery of vial contents. |